Comparison of the success rate of letrozole and clomiphene citrate in women undergoing intrauterine insemination

Journal of Research in Medical Sciences

Volumn 11, Issue 6, 2006, Pages 382-387

  Davar, Robab ^a   Asghamia, Maryam ^a   Tayebi, Mojgan ^a  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Clomiphene citrate; IUI; Letrozole; Superovulation

Indexed keywords

CLOMIFENE CITRATE; FOLLITROPIN; GONADOTROPIN; LETROZOLE; LUTEINIZING HORMONE; PROSTAGLANDIN E2; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CHI SQUARE TEST; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRIUM; FEMALE; FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; HUMAN; INFERTILITY THERAPY; INTRAUTERINE INSEMINATION; IRAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE INFERTILITY; MULTIPLE CYCLE TREATMENT; OVARY FOLLICLE; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY RATE; PROSTAGLANDIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SPONTANEOUS ABORTION; STATISTICAL SIGNIFICANCE; STUDENT T TEST; SUPEROVULATION; THICKNESS; TWIN PREGNANCY;

EID: 33847732576     PISSN: 17351995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Mitwally MF, Casper RF. Aromatase inhibitors for the treatment of infertility. Expert Opin Investig Drugs 2003; 12(3):353-371.
2. Shrivastav P. Aromatase inhibitors - their role in treatment of infertility. In: Das RB, Allahbadia GN, editors. The Art and Science of Assisted Reproductive Techniques. India: Taylor & Francis; 2004. p. 47-49.
3. Dickey RP, Holtkamp DE. Development, pharmacology and clinical experience with clomiphene citrate. Hum Reprod Update 1996; 2(6):483-506.
4. Hammond MG, Halme JK, Talbert LM. Factors affecting the pregnancy rate in clomiphene citrate induction of ovulation. Obstet Gynecol 1983; 62(2):196-202.
5. Carpenter SE. Implantation. In: Zacur HA, Wallach EE, editors. Reproductive Medicine and Surgery. St Louis: Mosby; 1995. p. 158-165.
6. Sereepapong W, Suwajanakorn S, Triratanachat S, Sampatanukul P, Pruksananonda K, Boonkasemsanti W et al. Effects of clomiphene citrate on the endometrium of regularly cycling women. Fertil Steril 2000; 73(2):287-291.
7. Gonen Y, Casper RF. Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth. Hum Reprod 1990; 5(6):670-674.
8. Geisler J, Haynes B, Anker G, Dowsett M, Lonning PE. Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study. J Clin Oncol 2002; 20(3):751-757.
9. Mitwally MF, Casper RF. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil Steril 2002; 77(4):776-780.
10. Mitwally MF, Casper RF. Single-dose administration of an aromatase inhibitor for ovarian stimulation. Fertil Steril 2005; 83(1):229-231.
11. Mitwally MF, Casper RF. Aromatase inhibitors in ovulation induction. Semin Reprod Med 2004; 22(1):61-78.
12. Mitwally MF, Casper RF. Aromatase inhibition for ovarian stimulation: future avenues for infertility management. Curr Opin Obstet Gynecol 2002; 14(3):255-263.
13. Winer EP, Hudis C, Burstein HJ, Chlebowski RT, Ingle JN, Edge SB et al. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002. J Clin Oncol 2002; 20(15):3317-3327.
14. Pfister CU, Martoni A, Zamagni C, Lelli G, De Braud F, Souppart C et al. Effect of age and single versus multiple dose pharmacokinetics of letrozole (Femara) in breast cancer patients. Biopharm Drug Dispos 2001; 22(5):191-197.
15. Akhtar M, Njar VC, Wright JN. Mechanistic studies on aromatase and related C-C bond cleaving P-450 enzymes. J Steroid Biochem Mol Biol 1993; 44(4-6):375-387.
16. Healey S, Tan SL, Tulandi T, Biljan MM. Effects of letrozole on superovulation with gonadotropins in women undergoing intrauterine insemination. Fertil Steril 2003; 80(6):1325-1329.
17. Mitwally MF, Casper RF. Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility. Hum Reprod 2003; 18(8):1588-1597.
18. Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 2001; 75(2):305-309.
19. Arcaini L, Bianchi S, Baglioni A, Marchini M, Tozzi L, Fedele L. Superovulation and intrauterine insemination vs. superovulation alone in the treatment of unexplained infertility. A randomized study. J Reprod Med 1996; 41(8):614-618.
20. Hughes EG. The effectiveness of ovulation induction and intrauterine insemination in the treatment of persistent infertility: a meta-analysis. Hum Reprod 1997; 12(9):1865-1872.
21. Zeyneloglu HB, Arici A, Olive DL, Duleba AJ. Comparison of intrauterine insemination with timed intercourse in superovulated cycles with gonadotropins: a meta-analysis. Fertil Steril 1998; 69(3):486-491.
22. Aboulghar MA, Mansour RT, Serour GI, Amin Y, Abbas AM, Salah IM. Ovarian superstimulation and intrauterine insemination for the treatment of unexplained infertility. Fertil Steril 1993; 60(2):303-306.
23. Van Voorhis BJ, Barnett M, Sparks AE, Syrop CH, Rosenthal G, Dawson J. Effect of the total motile sperm count on the efficacy and cost-effectiveness of intrauterine insemination and in vitro fertilization. Fertil Steril 2001; 75(4):661-668.
24. Zayed F, Lenton EA, Cooke ID. Comparison between stimulated in-vitro fertilization and stimulated intrauterine insemination for the treatment of unexplained and mild male factor infertility. Hum Reprod 1997; 12(11):2408-2413.
25. Fisher SA, Reid RL, Van Vugt DA, Casper RF. A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. Fertil Steril 2002; 78(2):280-285.
26. Al Fozan H, Al Khadouri M, Tan SL, Tulandi T. A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fertil Steril 2004; 82(6):1561-1563.
27. Franks S, Adams J, Mason H, Poison D. Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynaecol 1995; 12(3):605-632.
28. Hull MG, Armatage RJ, McDermott A. Use of follicle-stimulating hormone alone (urofollitropin) to stimulate the ovaries for assisted conception after pituitary desensitization. Fertil Steril 1994; 62(5):997-1003.
29. Mitwally MF, Biljan MM, Casper RF. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Obstet Gynecol 2005; 192(2):381-386.
30. Fatemi HM, Kolibianakis E, Toumaye H, Camus M, Van Steirteghem AC, Devroey P. Clomiphene citrate versus letrozole for ovarian stimulation: a pilot study. Reprod Biomed Online 2003; 7(5):543-546.
31. Mitwally MF, Casper RF. Aromatase inhibition: a novel method of ovulation induction in women with polycystic ovarian syndrome. Reprod Technol 2000; 10: 244-247.